A patient 60 year old ckd on mhd from 7 months complaining of high fever and chills from a day post hd and also last half hour of dialysis, access permacath and av fistula , suggestion medication in indian brand name and cause and investigation history of HCv with no viral load
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
hemodialysis catheter related bloodstream infection management
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Searching the Web
hemodialysis catheter related bacteremia treatment vancomycin Indian brand name 2024
I now have comprehensive data. Let me compile the full clinical answer.
Clinical Assessment: 60-Year-Old CKD on MHD (7 months) - Fever & Chills Post-HD
DIAGNOSIS: Catheter-Related Bacteremia (CRB) / Catheter-Related Bloodstream Infection (CRBSI)
This patient has a tunneled permacath (TDC) as the primary access concern. Fever and chills occurring during the last 30 minutes of dialysis and continuing post-HD is the classic presentation of catheter-related bacteremia - the permacath is the most likely source. The AV fistula, if mature, is a secondary concern but less likely as the cause.
"Catheter-related bacteremia is suspected when a catheter-dependent patient experiences fever or chills." - Brenner and Rector's The Kidney
"After 6 months with a dialysis catheter, approximately half of patients develop bacteremia, with a serious complication (death, endocarditis, osteomyelitis, septic arthritis, epidural abscess) occurring in 5% to 10% of patients with bacteremia." - Tintinalli's Emergency Medicine
CAUSATIVE ORGANISMS (Most Common)
| Rank | Organism | Frequency |
|---|---|---|
| 1 | Staphylococcus aureus (including MRSA) | >50% |
| 2 | Coagulase-negative staphylococci (CoNS) | ~32% |
| 3 | Gram-negative bacilli (E. coli, Klebsiella, Pseudomonas) | 15-20% |
| 4 | Enterococcus | <10% |
The high proportion of MRSA in dialysis patients is the primary reason vancomycin is empiric first choice.
RELEVANT HISTORY POINTS TO ELICIT
- Duration of permacath in situ (here 7 months - very high risk zone)
- Exit site appearance: erythema, discharge, tenderness at catheter insertion site or tunnel track
- Previous CRB episodes and organisms
- Prior antibiotics (antibiotic resistance risk)
- Recent dialysis adequacy (Kt/V trends) - poor flow suggests catheter dysfunction
- Signs of metastatic seeding: back pain (epidural abscess), joint pain (septic arthritis), cardiac murmur (endocarditis)
- HCV status: Patient has history of HCV with undetectable viral load - important context (see below)
- Diabetes, immunosuppression, malnutrition, iron overload status
- AV fistula: any swelling, redness, warmth, thrombosis over the fistula site
- Recent instrumentation, dental procedure, or skin break
INVESTIGATIONS
Urgent/Emergency
| Investigation | Rationale |
|---|---|
| Blood cultures x2 - one from catheter lumen + one peripheral (or dialysis bloodline) | Differential time to positivity (DTP >2 hours or 4-fold higher colony count from catheter = CRB confirmed) |
| CBC with differential | Leukocytosis, left shift |
| CRP, ESR, Procalcitonin | Severity, monitor treatment response |
| Serum electrolytes, BUN, creatinine | Baseline CKD status |
| LFTs, bilirubin | Baseline (HCV history, drug dosing) |
| Coagulation profile (PT/INR, APTT) | Sepsis workup |
| Chest X-ray | Rule out pneumonia, septic emboli |
| Blood sugar | Glycemia in sepsis |
Targeted Based on Findings
| Investigation | Indication |
|---|---|
| Echocardiography (TEE preferred) | If S. aureus bacteremia, or persistent fever >72 hours - rule out infective endocarditis |
| MRI spine / bone scan | If back pain - epidural abscess, vertebral osteomyelitis |
| Joint aspiration + synovial culture | If joint pain - septic arthritis |
| Catheter exit site swab culture | If exit site signs present |
| Urine culture | Rule out concurrent UTI |
Regarding HCV (Undetectable Viral Load)
| Test | Purpose |
|---|---|
| HCV RNA (quantitative PCR) - repeat now | Confirm current undetectable status; sepsis/immune stress can rarely reactivate |
| Anti-HCV antibody | Confirm serological status |
| LFTs (ALT, AST) | Hepatic inflammation |
| FibroScan or liver biopsy history | Assess fibrosis stage - relevant for drug dosing |
| HBsAg, anti-HBs, anti-HBc | Co-infection screening (common in dialysis population) |
Note: HCV with undetectable viral load in a dialysis patient most likely represents either spontaneous clearance or successful DAA treatment. The HCV itself is unlikely to cause this acute febrile illness, but the underlying liver status affects drug clearance and the risk of hepatotoxicity.
MANAGEMENT
Step 1: Immediate (ED / Dialysis Unit)
- Do NOT remove catheter immediately - obtain cultures first
- Admit the patient
- Empiric antibiotics within 1 hour of suspecting CRB
Step 2: Empiric Antibiotic Therapy
Vancomycin is the drug of choice (covers MRSA, all gram-positive organisms, long half-life of 5-7 days in dialysis patients).
| Drug | Dose in MHD | Indian Brand Names |
|---|---|---|
| Vancomycin (1st line - gram-positive/MRSA coverage) | Loading: 15-20 mg/kg IV (approx. 1-1.5 g) infused over 60-90 min; Maintenance: 500-750 mg IV at end of each HD session; Target trough: 15-20 mg/L | Vancomet (Sun Pharma), Vancosin (Pfizer), Stafcure (Cipla), Vancon (Cadila) |
| Gentamicin (add if gram-negative suspected) | 100 mg IV loading; then 100 mg post each HD session (monitor closely for ototoxicity and residual renal function) | Genticyn (Abbott India), Garamycin (Nicholas Piramal), Gentacin |
| Cefepime (gram-negative, alternative to gentamicin, less ototoxicity) | 1 g IV after each HD session | Cefomax (Sun), Kefage (Cipla), Maxicef |
| Piperacillin-Tazobactam (if Pseudomonas risk - catheter >6 months, prior hospitalization) | 2.25 g IV q8-12h (dose-reduce in dialysis; give after HD) | Tazobact (Cipla), Piperaz (Sun), Zosyn (Pfizer) |
| Meropenem (escalate if resistant gram-negative suspected) | 500 mg IV after each HD | Meronem (AstraZeneca India), Merotec (Cipla), Merowin |
"Vancomycin is the drug of choice (15 milligrams/kg or 1 gram IV) because of its effectiveness against methicillin-resistant organisms and long half-life (5 to 7 days) in dialysis patients." - Tintinalli's Emergency Medicine
Step 3: Antibiotic Lock Therapy (Catheter Salvage)
If catheter cannot be immediately removed, use antibiotic lock solution after each dialysis session:
- Vancomycin 2.5 mg/mL + Heparin 2500 units/mL instilled into each lumen and locked between HD sessions
- Instillation volume equals the internal catheter lumen volume (~1-1.5 mL per lumen)
- Success rate ~70% when combined with systemic antibiotics
- Not effective for S. aureus (remove catheter in this case)
Step 4: Catheter Decision (48-72 Hour Reassessment)
| Situation | Action |
|---|---|
| Fever resolves in 48-72 hours, low-virulence organism (CoNS) | Catheter salvage with antibiotic lock + systemic antibiotics x 3 weeks |
| Persistent fever >72 hours despite antibiotics | Mandatory catheter removal |
| S. aureus bacteremia confirmed | Remove catheter promptly; systemic antibiotics x 4-6 weeks |
| Tunnel track infection | Immediate catheter removal (oral/topical antibiotics will not suffice) |
| Septic shock, endocarditis, metastatic infection | Remove catheter + prolonged antibiotics |
If catheter removed: Insert temporary non-tunneled catheter 24-48 hours later (after bacteremia clears), then a new tunneled catheter once blood cultures negative.
Step 5: AV Fistula Assessment
- The AV fistula, if functioning, should be assessed for:
- Thrombosis (loss of bruit/thrill)
- Access site infection (erythema, pus - less common in native fistulas, 2-5% incidence)
- If fistula is mature and uninfected, prioritize transitioning the patient to fistula-based HD and removing the permacath at the earliest safe opportunity
HCV WITH UNDETECTABLE VIRAL LOAD - SPECIAL CONSIDERATIONS
This patient likely has achieved SVR (Sustained Virological Response) from prior DAA therapy, or has spontaneously cleared HCV. Key points:
- This is NOT the cause of the current fever - CRB is the culprit
- Drug dosing precautions: If significant hepatic fibrosis (cirrhosis) exists from prior HCV, it affects clearance of several antibiotics and increases bleeding risk
- No active HCV treatment needed if viral load is truly undetectable (SVR achieved)
- HCV transmission risk from dialysis remains - standard precautions must be followed
- Hepatic enzymes should be monitored during antibiotic therapy (drug hepatotoxicity risk)
SUPPORTIVE MANAGEMENT
| Measure | Detail |
|---|---|
| Antipyretics | Paracetamol (Crocin, Calpol) 500 mg oral/IV q6-8h - avoid NSAIDs in CKD |
| IV fluids | Cautious - risk of fluid overload in MHD; 100-200 mL NS bolus only if hypotensive |
| Continue HD | Do not stop dialysis; dialysis itself aids in vancomycin level management |
| DVT prophylaxis | Mechanical compression (avoid heparin-based prophylaxis if bleeding risk) |
| Nutrition | High-protein diet per nephrology dietitian |
SUMMARY ALGORITHM
Fever + Chills during/post-HD in Permacath patient
↓
Draw blood cultures (catheter + peripheral) STAT
↓
Empiric Vancomycin IV (15 mg/kg loading)
+ Cefepime/Gentamicin (if gram-negative risk)
↓
Assess exit site + tunnel track
↓
48-72 hour reassessment:
Fever resolved + CoNS/low-virulence → Antibiotic lock + salvage
Fever persists / S. aureus / tunnel infection → Remove catheter
↓
Culture-guided de-escalation at 72 hours
↓
If S. aureus: Echo to rule out endocarditis
Duration: 2-3 weeks (uncomplicated); 6 weeks (endocarditis)
Sources:
- Tintinalli's Emergency Medicine: A Comprehensive Study, Vascular Access Infections section
- Brenner and Rector's The Kidney, 2-Volume Set, Exchange of Tunneled Hemodialysis Catheters
- Comprehensive Clinical Nephrology, 7th Edition, Bacterial/Viral Infections in CKD
- Cochrane Systematic Review on CRB in MHD (PMID: 35363884) - 2022
- Comprehensive review of HD access infection management (PMID: 41251923) - 2026
Clinical Note: All drug doses listed are for patients on maintenance hemodialysis (MHD) with minimal/no residual renal function. Vancomycin levels must be monitored pre-HD to prevent accumulation. Gentamicin carries real ototoxicity risk even in anuric MHD patients - prefer cefepime if gram-negative cover is needed without ototoxicity concern. Consult infectious disease and nephrology for final antibiotic lock composition and duration.
After taking pcm but symptoms doesn't resolve please suggest medicine to resolve symptoms emediatly
Finding Sources
Finding Sources
Finding Sources
This is a clinical scenario I can answer directly from established nephrology/infectious disease knowledge. The key point here is critical: PCM (paracetamol) not resolving fever in catheter-related bacteremia is EXPECTED and expected - the fever is driven by bacteremia, not a simple pyrexia. The treatment is antibiotics, not stronger antipyretics.
Fever NOT Responding to Paracetamol in MHD Patient with Permacath
Why PCM Alone Will NOT Work Here
This is not a simple fever that antipyretics will resolve. The fever is caused by circulating bacteria and endotoxins from the infected permacath entering the bloodstream. Paracetamol can only reduce the hypothalamic set-point temporarily. Until the bacteremia is treated with antibiotics, fever and chills will persist or worsen.
Giving stronger antipyretics without starting antibiotics is dangerous and delays life-saving treatment.
Immediate Steps to Resolve Symptoms
1. START IV ANTIBIOTICS NOW (Most Important)
This is the only intervention that will break the fever cycle in CRB.
| Drug | Dose (MHD patient) | Indian Brand | Route |
|---|---|---|---|
| Vancomycin (1st line - MUST give) | 1-1.5 g IV infused over 90 min | Vancomet (Sun), Vancon (Cadila), Stafcure (Cipla) | IV slow infusion |
| Cefepime (add for gram-negative cover) | 1 g IV post-HD | Cefomax (Sun), Kefage (Cipla) | IV |
Fever typically begins to settle 4-8 hours after starting antibiotics once bacteremia starts clearing.
2. For Immediate Symptomatic Relief of Rigors/Chills
These drugs specifically target the chills and shivering that PCM cannot control:
Tramadol (most effective for rigors)
- Dose: 50 mg slow IV over 10 minutes OR 50 mg oral
- Indian brands: Tramazac (Zydus), Ultracet (Janssen, combination with PCM), Domtram (Cipla)
- Tramadol is the drug of choice for post-dialysis rigors - it acts centrally on thermoregulation
- Caution: Use with extreme care in CKD/dialysis - accumulation of metabolites. Use lowest dose (25-50 mg) once only if needed. Avoid repeat dosing.
Hydrocortisone (for severe rigors unresponsive to other measures)
- Dose: 100 mg IV stat
- Indian brands: Solu-Cortef (Pfizer), Efcortesol (GSK India), Hydrocort (Sun)
- Short-term single dose to break the rigor cycle; not for ongoing use
- Temporarily blunts the febrile/inflammatory response - do not use as routine - masks worsening sepsis
Pheniramine maleate (antihistamine for chills/rigors in dialysis reactions)
- Dose: 22.75 mg (1 ampoule) slow IV
- Indian brand: Avil injection (Sanofi India) - very widely used in Indian dialysis units for HD reactions including chills
- Works within 15-20 minutes for shivering/chills
- Safe in dialysis patients
3. Continue Paracetamol (Optimized)
If not already using IV form:
- Switch to Paracetamol IV infusion 1 g over 15 minutes (faster onset than oral)
- Indian brands: Perfalgan (Bristol-Myers Squibb India), Emeset formulations, PCM infusion (various generics)
- Repeat every 6 hours - do NOT exceed 4 g/day
4. Physical Measures (Immediate)
- Tepid sponging - lukewarm water on forehead, axilla, groin
- Remove excess blankets (patients wrap up during rigors - this traps heat and raises temperature further)
- Adequate room ventilation
What NOT to Give in This Patient
| Drug | Reason to Avoid |
|---|---|
| NSAIDs (Diclofenac/Ibuprofen) | Absolutely contraindicated in CKD/MHD - worsen residual renal function, cause fluid retention, GI bleed risk |
| Aspirin | Avoid - bleeding risk, no advantage over PCM |
| Metamizole/Dipyrone (Novalgin) | Agranulocytosis risk, not recommended |
| Repeated high-dose Tramadol | Metabolite accumulation in dialysis causes seizures |
Realistic Timeline of Symptom Resolution
| Timeframe | Expected |
|---|---|
| 15-30 minutes | Rigors/chills reduce with Avil + IV PCM |
| 2-4 hours | Shivering settles as antibiotics start working |
| 6-12 hours | Temperature begins trending down with appropriate antibiotics |
| 48-72 hours | Fever should fully resolve if correct antibiotic chosen |
If fever does NOT resolve within 48-72 hours of correct antibiotics → the permacath MUST be removed. Persistent fever is the key indicator for mandatory catheter removal.
Bottom line: Avil injection (Pheniramine) 22.75 mg IV + IV Paracetamol 1 g immediately for symptomatic relief of rigors. But the definitive treatment that will truly resolve symptoms is Vancomycin IV - this must be started without delay. Fever from bacteremia will not respond to any antipyretic alone.
This is a shared conversation. Sign in to Orris to start your own chat.